(Q44579046)

4 December 2017

Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering (English)

1 reference

4 December 2017

1 reference

1 reference

Hisayo Yokoyama

1

1 reference

4 December 2017

Shinya Fukumoto

2

1 reference

4 December 2017

Hidenori Koyama

3

1 reference

4 December 2017

Masanori Emoto

4

1 reference

4 December 2017

Yoshihiro Kitagawa

5

1 reference

4 December 2017

Yoshiki Nishizawa

6

1 reference

4 December 2017

1 September 2003

1 reference

Diabetes Research and Clinical Practice

4 December 2017

1 reference

4 December 2017

61

1 reference

4 December 2017

3

1 reference

4 December 2017

161-166

1 reference

Immunogenicity and allergenic potential of animal and human insulins

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Lispro analog for treatment of generalized allergy to human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

The insulin analog aspart: a safe alternative in insulin allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Altering the association properties of insulin by amino acid replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Monomeric insulins and their experimental and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Localized insulin allergy treated with continuous subcutaneous insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Human insulin analog insulin aspart does not cause insulin allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Use of low-dose continuous corticosteroid infusion to facilitate insulin pump use in local insulin hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Structure of insulin in 4-zinc insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Atomic force microscopy of crystalline insulins: the influence of sequence variation on crystallization and interfacial structure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

A case of insulin allergy: the crystalline human insulin may mask its antigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Immunoreactivity of Insulin Antibodies in Insulin-treated Diabetics: Significance of the Beta-chain Carboxyterminal Amino Acid (B-30) of Insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Primary systemic allergy to human insulin: recurrence of generalized urticaria after successful desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

CSII in management of insulin allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900114-1

7 January 2021

10.1016/S0168-8227(03)00114-1

Identifiers

DOI

1 reference

4 December 2017

1 reference